谷歌浏览器插件

订阅小程序

在清言上使用

立即登录

学术主页个人账号

我的关注论文收藏浏览历史

Supplementary Figures S1-S7 from Novel BCL-2 Inhibitor Lisaftoclax in Relapsed or Refractory Chronic Lymphocytic Leukemia and Other Hematologic Malignancies: First-in-Human Open-Label Trial

Sikander Ailawadhi,Zi Chen, Bo Huang,Aneel Paulus,Mary C. Collins,Lei (Tommy) Fu,Mingyu Li,Mohammad Ahmad,Lichuang Men,Hengbang Wang,Matthew S. Davids,Eric Liang, Divya J. Mekala,Zhicong He,Masa Lasica,Costas K. Yannakou, Ricardo Parrondo, Laura Glass,Dajun Yang,Asher Chanan-Khan,Yifan Zhai

crossref（2023）

引用 0|浏览10

暂无评分

摘要

These are all the Supplementary Figures: S1, S2, S3, S4, S5, S6, and S7

更多

查看译文

关键词

Treatment Discontinuation

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要